Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine Academic Article uri icon

Overview

MeSH Major

  • Antilymphocyte Serum
  • Cyclosporine
  • Immunosuppressive Agents
  • Pancreas Transplantation
  • Sirolimus

abstract

  • The absence of acute rejection events was likely due to inhibition of donor-specific immunity by the immunosuppressive regimen. Seventy percent of patients demonstrated an early, non-donor-directed HLA antibody response that had no adverse effect on graft function and 78% of the monitored patients displayed immunoregulatory cells probably contributing to the successful outcomes.

publication date

  • April 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/01.tp.0000203800.90554.07

PubMed ID

  • 16641593

Additional Document Info

start page

  • 1101

end page

  • 5

volume

  • 81

number

  • 8